Blood test catches hidden breast cancer before scans can see it

NCT ID NCT07069595

First seen Nov 01, 2025 · Last updated May 13, 2026 · Updated 29 times

Summary

This study is for people with a high-risk type of breast cancer (triple negative) who still have cancer after standard treatment and surgery. Researchers will use a simple blood test to look for tiny bits of cancer DNA that might be left in the body. If the blood test finds cancer, participants will get an experimental drug called Dato-DXd to try to stop the cancer from coming back. The goal is to see if this approach can catch and treat leftover cancer earlier than usual.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • UNC Lineberger Comprehensive Cancer Center

    RECRUITING

    Chapel Hill, North Carolina, 27514, United States

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

Conditions

Explore the condition pages connected to this study.